204
T. Zhu, G.-J. Boons / Tetrahedron: Asymmetry 11 (2000) 199–205
3.6. Ethyl 2-deoxy-2-acetamido-6-O-benzyl-3-O-(9-fluorenylmethoxycarbonyl)-4-O-levulinoyl-1-thio-
α-D-glucopyranoside 7
Compound 5 (81 mg, 0.1 mmol) was dissolved in acetic acid (2 ml) and zinc (nano-size activated
powder, 99.9%, 200 mg) was added. After stirring for 1 h, TLC analysis (ethyl acetate:hexanes, 1:2, v/v)
showed that the starting material was consumed. The reaction mixture was filtered through short pad of
silica gel (eluent: ethyl acetate) and the filtrate was concentrated under reduced pressure. The residue
was dissolved in a mixture of pyridine (3 ml) and acetic anhydride (2.5 ml). After stirring the reaction
mixture for 0.5 h, it was co-concentrated with toluene (3×15 ml) and the residue purified by silica gel
column chromatography (eluent: ethyl acetate:hexanes, 2:3, v/v) to give 7 as a white foam (58 mg, 86%).
1H NMR (500 MHz, CDCl3): δ 7.78–7.28 (m, 13H, Ar-H), 5.75 (d, 1H, NH, JNH,2=8.7 Hz), 5.51 (d,
1H, H-1, J1,2=5.5 Hz), 5.29 (t, 1H, H-4, J3,4= J4,5=9.6 Hz), 4.98 (dd, 1H, H-3, J2,3=11.5 Hz,), 4.64 (ddd,
1H, H-2), 4.55 (AB q, PhCH2, JAB=11.9 Hz), 4.40–4.36 (m, 3H, H-5, CH2O (Fmoc)), 4.28 (t, 1H, H-9
(Fmoc), J=7.8 Hz), 3.64 (dd, 1H, H-6a, J5,6a=2.7 Hz, J6a,6b=11.0 Hz), 3.61 (dd, 1H, H-6b, J5,6b=5.1 Hz),
2.71–2.58 (m, 4H, COCH2CH2, SCH2), 2.42 (t, 2H, COCH2CH2, J=6.9 Hz), 2.06 (s, 3H, CH3CO), 1.90
(s, 3H, NHCOCH3), 1.31 (t, 3H, SCH2CH3, J=7.2 Hz). 13C NMR (75 MHz, CDCl3): δ 206.2, 171,3,
169.9, 155.7, 143.5, 141.4, 138.1, 128.5, 128,1, 128.0, 127.8, 127.5, 127.4, 125.4, 120.2, 84.2, 75.9,
25
73.8, 70.9, 69.9, 69.2, 68.9, 52.8, 46.8, 38.1, 30.1, 28.2, 25.7, 23.7, 15.4. [α]D +18.8 (c 0.8, CH2Cl2).
MALDI-TOF MS: m/z 698 [M+Na]+. Anal. calcd for C37H41NO9S: C, 65.76; H, 6.12; N, 2.07; found:
C, 65.58; H, 6.14; N, 2.11.
3.7. 4-Alloxycarbonylpentoxybenzyl
6-O-benzyl-3-O-(9-fluorenylmethoxycarbonyl)-4-O-levulinoyl-
2-deoxy-2-[[(2,2,2-trichloroethoxy)carbonyl]amino]-β-D-glucopyranoside 9
A solution of 5 (162 mg, 0.2 mmol) and 8 (61 mg, 0.22 mmol) in dichloromethane (4 ml) was stirred
in the presence of 4 Å molecular sieves (100 mg, powdered) for 15 min. The mixture was cooled (0°C)
and NIS (50 mg, 0.22 mmol) and TMSOTf (4 µl, 22 µmol) were added. After 5 min, TLC analysis
(ethyl acetate:hexanes, 1:1, v/v) showed that compound 5 was consumed. The reaction mixture was
diluted with dichloromethane (50 ml), filtered, and the filtrate was washed successively with aqueous
sodium thiosulfate (15%, 2×25 ml), water (20 ml), and brine (15 ml). The organic phase was dried
(MgSO4), filtered, and the filtrate was concentrated in vacuo. Purification of the residue by silica gel
column chromatography (eluent: ethyl acetate:hexanes, 1:2, v/v) gave 9 as an amorphous solid (154
1
mg, 75%). H NMR (500 MHz, CDCl3): δ 7.77–6.83 (m, 17H, Ar-H), 5.98–5.90 (m, 1H, CH_CH2),
5.36–5.25 (m, 2H, CH_CH2), 5.22–5.16 (m, 2H, H-3, H-4), 5.09 (br s, 1H, NH), 4.87–4.57 (m, 9H,
H-1, PhCH2, OCH2CCl3, CH2CH_CH2, CH2O (Fmoc)), 4.27 (t, 1H, H-9 (Fmoc), J=7.6 Hz), 3.97
(t, 2H, PhOCH2CH2, J=6.4 Hz), 3.75–3.64 (m, 4H, H-2, H-5, H-6a, H-6b), 2.59 (t, 2H, COCH2CH2,
J=5.2 Hz), 2.42–2.38 (m, 4H, COCH2CH2, CH2COOAll), 2.04 (s, 3H, CH3CO), 1.85–1.50 (m, 6H,
OCH2CH2CH2CH2CH2). 13C NMR (75 MHz, CDCl3): δ 205.9, 173.4, 171.5, 159.1, 155.1, 154.0,
143.5, 141.4, 138.1, 132.4, 130.0, 128.7, 128.5, 128.1, 128.0, 127.9, 127.4, 125.5, 120.2, 118.4, 114,7,
100.3, 98.7, 95.6, 76.4, 74.7, 73.9, 73.6, 70.8, 69.8, 69.3, 67.9, 65.3, 56.8, 46.8, 38.0, 34.5, 29.9, 29.3,
25
28.1, 26.0, 25.0. [α]D −4.6 (c 0.2, CH2Cl2). MALDI-TOF MS: m/z 1046 [M+Na]+. Anal. calcd for
C52H56Cl3NO14: C, 60.91; H, 5.50; N, 1.37; found: C, 60.98; H, 5.66; N, 1.32.
3.8. 4-Hydroxylcarbonylpentoxybenzyl 6-O-benzyl-3-O-(9-fluorenylmethoxycarbonyl)-4-O-levulinoyl-
2-deoxy-2-[[(2,2,2-trichloroethoxy)carbonyl]amino]-β-D-glucopyranoside 10
Pd(PPh3)4 (12 mg, 0.01 mmol) was added to a solution of compound 9 (103 mg, 0.1 mmol) in
ethanol (2 ml), THF (2 ml), and water (0.2 ml). After stirring the reaction mixture for 2 h at 60°C,